These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29535775)

  • 1. Stem Cell Therapy in Patients with Chronic Nonischemic Heart Failure.
    Poglajen G; Zemljič G; Frljak S; Cerar A; Andročec V; Sever M; Černelč P
    Stem Cells Int; 2018; 2018():6487812. PubMed ID: 29535775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell therapy for chronic heart failure.
    Poglajen G; Vrtovec B
    Curr Opin Cardiol; 2015 May; 30(3):301-10. PubMed ID: 25827394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem Cell Therapy for Chronic and Advanced Heart Failure.
    Poglajen G; Frljak S; Zemljič G; Cerar A; Okrajšek R; Šebeštjen M; Vrtovec B
    Curr Heart Fail Rep; 2020 Oct; 17(5):261-270. PubMed ID: 32783146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Benefits of Stem Cells for Chronic Symptomatic Systolic Heart Failure: A Systematic Review of the Existing Data and Ongoing Trials.
    Poulin MF; Deka A; Mohamedali B; Schaer GL
    Cell Transplant; 2016 Nov; 25(11):1911-1923. PubMed ID: 27349212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
    Tompkins BA; Rieger AC; Florea V; Banerjee MN; Natsumeda M; Nigh ED; Landin AM; Rodriguez GM; Hatzistergos KE; Schulman IH; Hare JM
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamic cardiomyoplasty: evaluation of an alternative procedure in the treatment of terminal heart failure].
    Voss B; Lange R
    Z Kardiol; 2001; 90 Suppl 1():22-7. PubMed ID: 11261336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary Challenges of Regenerative Therapy in Patients with Ischemic and Non-Ischemic Heart Failure.
    Banovic M; Poglajen G; Vrtovec B; Ristic A
    J Cardiovasc Dev Dis; 2022 Dec; 9(12):. PubMed ID: 36547426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy.
    Razeghian-Jahromi I; Matta AG; Canitrot R; Zibaeenezhad MJ; Razmkhah M; Safari A; Nader V; Roncalli J
    Stem Cell Res Ther; 2021 Jun; 12(1):361. PubMed ID: 34162424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell therapy for ischemic heart diseases.
    Yu H; Lu K; Zhu J; Wang J
    Br Med Bull; 2017 Jan; 121(1):135-154. PubMed ID: 28164211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease.
    Ripa RS
    Dan Med J; 2012 Mar; 59(3):B4411. PubMed ID: 22381094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cell therapy and cytokine therapy for functional repair in ischemic and nonischemic heart failure.
    Li TS; Mikamo A; Takahashi M; Suzuki R; Ueda K; Ikeda Y; Matsuzaki M; Hamano K
    Cell Transplant; 2007; 16(4):365-74. PubMed ID: 17658127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art.
    Charwat S; Gyöngyösi M; Lang I; Graf S; Beran G; Hemetsberger R; Nyolczas N; Sochor H; Glogar D
    Exp Hematol; 2008 Jun; 36(6):672-80. PubMed ID: 18358589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Fisher SA; Brunskill SJ; Doree C; Mathur A; Taggart DP; Martin-Rendon E
    Cochrane Database Syst Rev; 2014 Apr; (4):CD007888. PubMed ID: 24777540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit
    Bolli R; Hare JM; March KL; Pepine CJ; Willerson JT; Perin EC; Yang PC; Henry TD; Traverse JH; Mitrani RD; Khan A; Hernandez-Schulman I; Taylor DA; DiFede DL; Lima JAC; Chugh A; Loughran J; Vojvodic RW; Sayre SL; Bettencourt J; Cohen M; Moyé L; Ebert RF; Simari RD;
    Circ Res; 2018 Jun; 122(12):1703-1715. PubMed ID: 29703749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State of the art of stem cell therapy for ischaemic cardiomyopathy. Part 1.
    Maslovaric M; Fatic N; Delević E
    Angiol Sosud Khir; 2019; 25(3):39-52. PubMed ID: 31503246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational research of adult stem cell therapy.
    Suzuki G
    World J Cardiol; 2015 Nov; 7(11):707-18. PubMed ID: 26635920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REVIVE Trial: Retrograde Delivery of Autologous Bone Marrow in Patients With Heart Failure.
    Patel AN; Mittal S; Turan G; Winters AA; Henry TD; Ince H; Trehan N
    Stem Cells Transl Med; 2015 Sep; 4(9):1021-7. PubMed ID: 26217065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy.
    Wang X; Zhang J; Zhang F; Li J; Li Y; Tan Z; Hu J; Qi Y; Li Q; Yan B
    Stem Cells Int; 2015; 2015():135023. PubMed ID: 26101528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Stem Cells Improve Left Ventricular Ejection Fraction in Heart Failure? A Literature Review of Skeletal Myoblasts and Bone Marrow-Derived Cells.
    Cheung MM; Jahan N
    Cureus; 2020 Nov; 12(11):e11598. PubMed ID: 33364119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.